Elan's (ELN) Theravance Deal a 'Lunker' - Jefferies

May 13, 2013 8:15 AM EDT Send to a Friend
Jefferies analyst Corey Davis, Ph.D. reiterated his Buy rating and $14 price target on Elan Corp (NYSE: ELN) calling the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login